Mitral kapak cerrahisi 2014 kilavuzlarinda dr. gokhan lafci
Expanding the role of covered stents for aneurysmal and stenotic lesions
1. Expanding the role of covered stents
for aneurysmal and stenotic lesions
M.H.Tenholt
Vascular and Endovascular Surgery
Theresien Hospital Mannheim - Germany
2. Matthias.Tenholt@theresienkrankenhaus.de
Superior patency for iliac stenting
Iliac stenting
Patency @
12 months 18 months 24 months 60 months
CS 95%
BMS 82%
Sabri et al CS 92% 92%
BMS 78% 62%
Bosiers et al CS 91%
Dartmouth et al CS 87%
BMS 53%
Cerezo et al CS 100% 86%
3. Matthias.Tenholt@theresienkrankenhaus.de
Renal and visceral stenting
Patency at:
12 months 24 months 36 months
Renal
Mohabbat/Greenberg et al CS 95%
BMS 83%
Hassis et al CS 100% 93%
BMS 83% 74%
Mesenteric
Lesar et al CS 100%
BMS 54%
Oderich et al CS 92%
BMS 52%
Superior patency for renal and
visceral stenting
88. Matthias.Tenholt@theresienkrankenhaus.de
Conclusion V12 Covered Stents
Covered stent: not only for acute problems
Covered stents are the prefered implants in aortoiliac
occlusive lesions (TASC C & D lesions)
Can be used in plaque ulcerations and small
aneurysmal/occlusive lesions
Usefull as a “stent in-stent“ concept in redo cases and
they are then preferable to open surgery
89. Expanding the role of covered stents
for aneurysmal and stenotic lesions
Thank you
Dr. M.H.Tenholt
matthias.tenholt@theresienkrankenhaus.de